XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.24.3

Capital Stock, Stock Plans and Stock-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Share-based Compensation, Allocation of Recognized Period Costs | The following table summarizes stock-based compensation recognized for the three and nine months ended September 30, 2024, and 2023 for our employee and director stock options. Schedule of Share-based Compensation, Allocation of Recognized Period Costs
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | Three Months Ended |  |  | Nine Months Ended |
Stock Options |  | September 30, |  |  | September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Employee Stock Options |  | $ | 96,000 |  |  | $ | 94,000 |  |  | $ | 259,000 |  |  | $ | 273,000 |
Director Stock Options |  |  | 86,000 |  |  |  | 55,000 |  |  |  | 207,000 |  |  |  | 119,000 |
Total |  | $ | 182,000 |  |  | $ | 149,000 |  |  | $ | 466,000 |  |  | $ | 392,000 |
Schedule of Stock Options Roll Forward | The summary of the Company’s stock option plans as of September 30, 2024, and September 30, 2023, and changes during the periods then ended, are presented below. The Company’s plans consist of the 2017 Plan and the 2003 Plan: Schedule of Stock Options Roll Forward
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (4) |
Options outstanding January 1, 2024 |  |  | 994,500 |  |  | $ | 5.57 |  |  |  |  |  |  |  | - |
Granted |  |  | 150,500 |  |  | $ | 9.43 |  |  |  |  |  |  |  |  |
Exercised |  |  | (58,700 | ) |  | $ | 5.57 |  |  |  |  |  |  | $ | 306,574 |
Forfeited |  |  | (46,400 | ) |  | $ | 5.93 |  |  |  |  |  |  |  |  |
Options outstanding end of period (1) |  |  | 1,039,900 |  |  | $ | 6.12 |  |  |  | 4.8 |  |  | $ | 6,397,354 |
Options exercisable at September 30, 2024(2) |  |  | 386,000 |  |  | $ | 5.31 |  |  |  | 4.0 |  |  | $ | 2,684,482 |
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (4) |
Options outstanding January 1, 2023 |  |  | 1,018,400 |  |  | $ | 5.02 |  |  |  |  |  |  |  | - |
Granted |  |  | 365,000 |  |  | $ | 3.19 |  |  |  |  |  |  |  |  |
Exercised |  |  | (282,400 | ) |  | $ | 3.70 |  |  |  |  |  |  | $ | 2,118,892 |
Forfeited/expired/cancelled |  |  | (64,500 | ) |  | $ | 3.67 |  |  |  |  |  |  |  |  |
Options outstanding end of period (2) |  |  | 1,036,500 |  |  | $ | 5.48 |  |  |  | 5.1 |  |  | $ | 5,146,126 |
Options exercisable at September 30, 2023(3) |  |  | 302,300 |  |  | $ | 4.91 |  |  |  | 3.9 |  |  | $ | 1,675,604 |
(1) | Options with exercise prices ranging from $3.15 to $10.20
(2) | Options with exercise prices ranging from $3.15 to $9.81
(3) | Options with exercise prices ranging from $3.15 to $7.50
(4) | The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration